Hizentra is an Ig* therapy that provides proven protection for PI and CIDP with the convenience of self-administration, so you can focus on everyday living
Hizentra is a subcutaneous infusion therapy, which means IV access is not involved.
Instead, you can self-administer by infusing just under the skin, not into your veins, after receiving training from your doctor.
Hizentra gives you proven protection with convenient dosing to best fit your lifestyle and preference.
Hizentra is a prescription medicine used to treat primary immune deficiency (Pl) in patients 2 years and older and as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
With Premier Start, you can receive:
The Hizentra Co-Pay Relief program helps eligible people afford their therapy by assisting with monthly out-of-pocket expenses for Hizentra (up to $5,000 for each year, with no monthly cap). Most patients with commercial insurance pay $0 out-of-pocket.See if you are eligible
CSL Behring Assurance is a program that can help eligible patients continue to receive treatment even if they experience a lapse in third-party private health insurance.Learn how it works
This kit provides important resources to help you start and stay on Hizentra.